Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Envela Corp. (ELA)
AMEXConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
$10.81-7.61%
Close 2026-11-05 · 1-day change
AMEXConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.64 → 0.64 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ELA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stock buyback plan remains active through 2028 | The company extended its stock buyback plan to 2028. | Intact | Buyback plan is canceled or not extended past 2026 | Buyback active through 2028-03-31 vs target 2028-03-31 April 2026 announcement confirms extension of stock repurchase plan expiration to March 31, 2028. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ELA is a smaller-cap, growth-sensitive business with strong recent financial performance and robust earnings quality. Its long-term thesis is intact, though risk remains elevated and recent earnings surprises have been erratic.
The valuation evidence describes ELA as cheap versus peers, with a negative expectations gap, meaning expectations appear more cautious than the valuation model’s view. The priced-in assessment is tagged as justified, and fragility is low, so the snapshot does not point to concentrated expectations risk.
Near term, revenue rose to $98.38 million in 2026-Q1 from $80.50 million in 2025-Q4, while operating income rose to $11.21 million from $7.53 million. Both trends align with management’s stated priorities, but the smaller-cap profile and uneven earnings surprises leave some risk of a missed result.
Over the next one to three years, the thesis depends in part on whether management sustains revenue growth and improves operating income. Consumer-sector momentum could help if major sector companies keep reporting strong results, while weaker results or GDP growth slowing materially from 2.1% could weigh on this growth-sensitive business.
The multi-year view remains intact, supported by recent operating progress and a valuation described as cheap versus peers, but sector exposure and elevated risk are key conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Envela Corp.'s published investment case. The stated target is >= $11 million. |
| Under Pressure |
| Operating income falls below $11 million next year |
Operating income: $5.102M FY2026-Q2; GAAP. Published target: >= $11 million. Target period is not explicitly aligned with this observation. Aug 5, 20265,102,456 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of last 3 quarters. Operating income rose to $11.21M in 2026-Q1 from $7.53M in 2025-Q4, reflecting management's focus on improving profitability. The trajectory is delivering positive results. Delivery assessment Jul 9, 2026 |
Revenue grows at least 5% annually | A primary condition in Envela Corp.'s published investment case. The stated target is >=5% YoY. | Broken | YoY revenue growth falls below 5% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of last 3 quarters. Revenue increased to $98.38M in 2026-Q1 from $80.50M in 2025-Q4, showing a strong growth trajectory. This aligns with management's focus on revenue growth, indicating delivering progress. Delivery assessment Jul 9, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.66 → $0.64 · observed estimates
$0.25B → $0.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.66 | $250,067,500 | 1 / 1 |
| 2026-07-25 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-07-26 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-07-27 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-07-28 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-07-29 | $0.66 | $250,067,500 | 1 / 1 |
| 2026-07-30 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-07-31 | $0.66 | $250,067,500 | 1 / 1 |
| 2026-08-01 | $0.66 | $250,067,500 | 1 / 1 |
| 2026-08-02 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-08-03 | $0.66 | $250,067,500 | 1 / 1 |
| 2026-08-04 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-08-05 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-08-06 | $0.66 | $250,070,000 | 2 / 2 |
| 2026-08-07 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-08 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-09 | $0.64 | $244,731,000 | 2 / 2 |
| 2026-08-10 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-11 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-12 | $0.64 | $244,731,000 | 2 / 2 |
| 2026-08-13 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-14 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-15 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-16 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-17 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-18 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-19 | $0.66 | $245,704,500 | 1 / 1 |
| 2026-08-20 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-21 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-22 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-23 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-24 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-25 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-26 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-27 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-28 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-29 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-30 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-08-31 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-01 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-02 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-03 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-04 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-05 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-06 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-07 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-08 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-09 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-10 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-11 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-12 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-13 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-14 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-15 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-16 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-17 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-18 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-19 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-20 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-21 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-22 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-23 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-24 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-25 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-26 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-27 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-28 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-29 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-09-30 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-01 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-02 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-03 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-04 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-05 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-06 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-07 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-08 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-09 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-10 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-11 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-12 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-13 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-14 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-15 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-16 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-17 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-18 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-19 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-20 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-21 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-22 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-23 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-24 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-25 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-26 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-27 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-28 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-29 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-30 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-10-31 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-11-01 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-11-02 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-11-03 | $0.64 | $244,731,000 | 1 / 1 |
| 2026-11-04 | $0.64 | $244,731,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.